Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Zundler

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Frontiers in Pharmacology|February 19, 2019
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel DiseaseCharlotte Lichnog, Sha Klabunde, Emily Becker, et al.
Gut|August 31, 2021
Residual homing of α4β7-expressing β1<sup>+</sup>PI16<sup>+</sup> regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumabEmily Becker, Mark Dedden, Christine Gall, et al.
Nature Communications|February 3, 2024
Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cellsMaximilian Wiendl, Mark Dedden, Li-Juan Liu, et al.
Frontiers in Nutrition|May 17, 2024
Fiber rich food suppressed airway inflammation, GATA3 + Th2 cells, and FcεRIα+ eosinophils in asthmaAlicia Schenzel, Adriana Geiger, Elvedina Nendel, et al.
Journal of Crohn'S & Colitis|April 27, 2016
Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel DiseasesImke Atreya, Alexandra Diall, Radovan Dvorsky, et al.
Nature Communications|April 16, 2025
Inflammatory conditions shape phenotypic and functional characteristics of lung-resident memory T cells in miceAnna Schmidt, Jana Fuchs, Mark Dedden, et al.
Frontiers in Immunology|May 28, 2020
ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory FailureAnja Schulz-Kuhnt, Vicky Greif, Kai Hildner, et al.
Journal of Neuroinflammation|June 27, 2026
Csf1r-mediated depletion of myeloid cells prevents dopaminergic neuron loss during chronic colitisRebecca Katharina Kutscherauer, Marie Andert, Iris Stolzer, et al.
Gut|April 16, 2022
Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitisCaroline Voskens, Diane Stoica, Marita Rosenberg, et al.
Journal of Crohn'S & Colitis|October 21, 2019
The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative ColitisHeike Schmitt, Julia Ulmschneider, Ulrike Billmeier, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Frontiers in Pharmacology|February 19, 2019
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel DiseaseCharlotte Lichnog, Sha Klabunde, Emily Becker, et al.
Gut|August 31, 2021
Residual homing of α4β7-expressing β1<sup>+</sup>PI16<sup>+</sup> regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumabEmily Becker, Mark Dedden, Christine Gall, et al.
Nature Communications|February 3, 2024
Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cellsMaximilian Wiendl, Mark Dedden, Li-Juan Liu, et al.
Frontiers in Nutrition|May 17, 2024
Fiber rich food suppressed airway inflammation, GATA3 + Th2 cells, and FcεRIα+ eosinophils in asthmaAlicia Schenzel, Adriana Geiger, Elvedina Nendel, et al.
Journal of Crohn'S & Colitis|April 27, 2016
Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel DiseasesImke Atreya, Alexandra Diall, Radovan Dvorsky, et al.
Nature Communications|April 16, 2025
Inflammatory conditions shape phenotypic and functional characteristics of lung-resident memory T cells in miceAnna Schmidt, Jana Fuchs, Mark Dedden, et al.
Frontiers in Immunology|May 28, 2020
ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory FailureAnja Schulz-Kuhnt, Vicky Greif, Kai Hildner, et al.
Journal of Neuroinflammation|June 27, 2026
Csf1r-mediated depletion of myeloid cells prevents dopaminergic neuron loss during chronic colitisRebecca Katharina Kutscherauer, Marie Andert, Iris Stolzer, et al.
Gut|April 16, 2022
Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitisCaroline Voskens, Diane Stoica, Marita Rosenberg, et al.
Journal of Crohn'S & Colitis|October 21, 2019
The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative ColitisHeike Schmitt, Julia Ulmschneider, Ulrike Billmeier, et al.
Pageof 10